Pharmafile Logo
Pharmafocus logo
Advanced Search

Pharma supply chain event LogiPharma celebrates another successful year

April 28, 2025
Industry Associations, Medical Communications Cold Chain Technologies, DB Schenker, LogiPharma, Pharmacy, PluumoPlus, supply chain event, supply chain professionals

In Lyon, France, over 2,200 life sciences supply chain professionals gathered for LogiPharma 2025, a leading conference dedicated to supply …

News
clinical_trials

Successful clinical outcomes for drug treating rare stroke condition

April 25, 2025
Research and Development Bioxodes, Neurology, clinical trial, stroke

Flemish biopharma company, Bioxodes, has announced promising results from the BIRCH phase 2a clinical trial of BIOX-101 to treat intracerebral …

News
trialy

Mosaic Therapeutics in-licenses clinical oncology programmes from Astex Pharma

April 25, 2025
Clinical Trial Services, Industry Associations, Mergers and Acquisitions, Research and Development Astex pharmaceuticals, Mosaic Therapeutics, Oncology, clinical trial

Two clinical-stage oncology programmes from Astex Pharmaceuticals have been announced by Mosaic Therapeutics, allowing it to develop targeted oncology drug …

News

Philippe Masset appointed to Vect-Horus board of directors

April 25, 2025
Research and Development Oncology, Vect-Horus, appointment, board of directors, imaging agents

Vect-Horus has announced the appointment of Philippe Masset to the company’s board of directors. This contributes to a series of …

Appointment
blood_tests_pic

Mursla Bio’s platform for surveillance of liver cancer receives FDA approval

April 24, 2025
Industry Associations, Research and Development BDD, FDA, Mursla Bio, Oncology, hepatocellular carcinoma (HCC), liver disease

The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to EvoLiver, Mursla Bio’s surveillance platform for …

News

Hansa Biopharma appoints Renée Aguiar-Lucander as CEO

April 24, 2025
Research and Development CEO, Corporate, Hansa Biopharma, appointment, immunology

Swedish biopharma company, Hansa Biopharma, has announced the appointment of new chief executive officer (CEO) Renée Aguiar-Lucander, replacing Søren Tulstrup …

Appointment

Neurizon makes appointments to executive team

April 24, 2025
Recruitment, Senior Management Neurizon, Neurology, als, biotech, neurodegenerative diseases

Neurizon Therapeutics, a clinical-stage biotech company focusing on treatments for neurodegenerative diseases, has announced three leadership appointments. These will support …

Appointment

ViroCell and UCL launch trial to treat childhood leukaemia relapse

April 24, 2025
Research and Development Oncology, UCL, ViroCell, acute lymphoblastic leukaemia, cell therapy, clinical trial, leukaemia

ViroCell Biologics has manufactured a GMP-grade lentiviral vector for a University College London (UCL) clinical trial aimed at tackling relapse …

News

Dual immunotherapy for bowel cancer now available under NHS

April 23, 2025
Research and Development Bristol Myer Squibb, MHRA, NICE, Oncology, bowel cancer, colorectal cancer, immunotherapy

Dual immunotherapy, a combination of Opdivo (nivolumab) and Yervoy (ipilimumab), has been granted extension in the UK by the Medicines …

News

CARBOGEN AMCIS manufacturing license advances services in China

April 23, 2025
Manufacturing Services, Manufacturing and Production Carbogen Amcis, China, Corporate, Drug Manufacturing License (DML), Shanghai, manufacturing

Swiss pharma manufacturing company, CARBOGEN AMCIS, has announced that its facility in Shanghai, China, has been successfully granted Drug Manufacturing …

News
handshake_2

AOTI diabetic foot care therapy to be used by NHS

April 23, 2025
Research and Development AOTI, Diabetes, diabetes, diabetic foot care, health economic study

Effective from September 2025, AOTI’s Topical Wound Oxygen (TWO2) therapy has been awarded inclusion in the NHS supply chain. It …

News

Galapagos announces leadership changes amid planned company split

April 22, 2025
Analytical & Laboratory Services, Research and Development CEO Appointment, Corporate, Galapagos, cell therapy

Galapagos NV has announced key leadership changes as it prepares to separate into two independent entities. Henry Gosebruch has been …

Appointment

Kidney Research UK backs digital innovation to support 15 million patients with long-term conditions

April 22, 2025
Medical Education, Patient Awareness Programmes, Public Relations Cognitant Group, Kidney Research UK, Nephrology, chronic kidney disease (CKD)

Kidney Research UK has announced an ambitious investment in the patient engagement platform Healthinote, developed by Cognitant Group, in a …

News

Meribel Pharma Solutions launches to take pharma services to new heights

April 22, 2025
Manufacturing Services, Manufacturing and Production CMDO, Corporate, Meribel Pharma Solutions, manufacturing

Meribel Pharma Solutions, a new mid-sized contract development and manufacturing organisation (CDMO), has officially launched with operations across 13 sites …

News

Allegro confirms successful safety testing of osteoarthritis treatment

April 17, 2025
Research and Development Allegro, Osteoporosis, joint disease, oesteoarthritis, pretrial

Allegro’s hydrocelin treatment for osteoarthritis has demonstrated a satisfactory safety profile, giving it potential to become a leading disease-modifying treatment …

News
blood_test

Johnson & Johnson announces successful results from trial for myeloma treatment

April 16, 2025
Research and Development Johnson & Johnson, Oncology, myeloma, pharma, trial

Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed significantly longer progression-free survival (PFS) …

News

Astraveus expands leadership team ahead of Lakhesys launch

April 16, 2025
Manufacturing Services Astraveus, Corporate, appointment

Astraveus has announced a series of senior appointments as it advances towards the launch of its Lakhesys Benchtop Cell Factory, …

Appointment

Moderna authorised to upscale development of mRNA vaccines in UK

April 15, 2025
Manufacturing and Production Moderna, UK, UK government, Virology, mrna, vaccination

Global researcher of mRNA medicine, Moderna, has been granted authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) to …

News

ProQR appoints new CFO and CMO to drive clinical-stage growth

April 15, 2025
Research and Development Corporate, ProQR, appointments, clinical development

ProQR Therapeutics announced two major leadership appointments to support its transition into the clinical development phase of its RNA editing …

Appointment

Survey suggests Britons with a disability are concerned over AI-integrated healthcare

April 14, 2025
Business Services, Consultancy, Medical Communications AI, Consultancy, Corporate, Pharmacy, nuom, survey

A survey conducted by nuom, a British healthcare consultancy, found a majority of UK adults with a disability are concerned …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025